스페인 -
스페인어 -
AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
alprazolam aristo 2 mg comprimidos efg
aristo pharma iberia s.l. - alprazolam - comprimido - 2 mg - alprazolam 2 mg - alprazolam
스페인 -
스페인어 -
AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
acidos omega 3 aristo 1000 mg capsulas blandas efg
aristo pharma iberia s.l. - acidos omega 3 esteres etilicos - cÁpsula blanda - 1.000 mg - acidos omega 3 esteres etilicos 1000 mg - triglicéridos omega-3, incluidos otros ésteres y ácidos
스페인 -
스페인어 -
AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
fyremadel 0,25 mg / 0,5 ml solucion inyectable en jeringa precargada efg
sun pharmaceutical industries (europe) b.v. - ganirelix - soluciÓn inyectable - 0,25 mg inyectable 0,5 ml - ganirelix 0,5 mg - ganirelix
유럽 연합 -
스페인어 -
EMA (European Medicines Agency)
byooviz
samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - oftalmológicos - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
유럽 연합 -
스페인어 -
EMA (European Medicines Agency)
ranivisio
midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmológicos - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).
스페인 -
스페인어 -
AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
astarte 0,25 mg/0,5 ml solucion inyectable en jeringa precargada efg
gp pharm s.a. - ganirelix - soluciÓn inyectable en jeringa precargada - 0,25 mg inyectable 0,5 ml - ganirelix 0,5 mg - ganirelix
유럽 연합 -
스페인어 -
EMA (European Medicines Agency)
ximluci
stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmológicos - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
스페인 -
스페인어 -
AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
tadalafilo aristo 5 mg comprimidos recubiertos con pelicula efg
aristo pharma gmbh - tadalafilo - comprimido recubierto con pelÍcula - 5 mg - tadalafilo 5 mg - tadalafilo
스페인 -
스페인어 -
AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
irbesartan aristo 150 mg comprimidos recubiertos con pelicula efg
aristo pharma iberia s.l. - irbesartan - comprimido recubierto con pelÍcula - 150 mg - irbesartan 150 mg - irbesartán
스페인 -
스페인어 -
AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
irbesartan aristo 300 mg comprimidos recubiertos con pelicula efg
aristo pharma iberia s.l. - irbesartan - comprimido recubierto con pelÍcula - 300 mg - irbesartan 300 mg - irbesartán